| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |